Jacksonville Center for Clinical Research

Mixed experience with the Sunshine Act

Monday, August 1, 2016

Pharmaceutical companies have finished submitting the third batch of data detailing their financial relationships with physicians and teaching hospitals under the Open Payments program, also referred to as the Physician Payment Sunshine Act. Investigators now face the prospect of implementing sophisticated new processes and systems that can track and verify clinical research grant payment information.

[Read More]

Sites smothered by technology solutions

Sunday, May 1, 2016

Technology solutions help sponsors and CROs make better drug development decisions, streamline processes and reduce clinical trial costs. But for a majority of investigative sites, these same technologies get in the way of efficient operations and add to their already heavy workload.

[Read More]

Regulatory compliance an increasing burden on sites

Wednesday, April 1, 2015

As the biopharmaceutical industry strives to reduce its R&D costs and shorten timelines, it must face the fact that to­day’s successful drug development plans often require more clinical studies than they did a dozen years ago.

[Read More]